T cell activation contributes to purifying selection against the MELAS-associated m.3243A>G pathogenic variant in blood

IF 4.2 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Melissa A. Walker, Shuqiang Li, Kenneth J. Livak, Amel Karaa, Catherine J. Wu, Vamsi K. Mootha
{"title":"T cell activation contributes to purifying selection against the MELAS-associated m.3243A>G pathogenic variant in blood","authors":"Melissa A. Walker,&nbsp;Shuqiang Li,&nbsp;Kenneth J. Livak,&nbsp;Amel Karaa,&nbsp;Catherine J. Wu,&nbsp;Vamsi K. Mootha","doi":"10.1002/jimd.12726","DOIUrl":null,"url":null,"abstract":"<p>T cells have been shown to maintain a lower percentage (heteroplasmy) of the pathogenic m.3243A&gt;G variant (<i>MT-TL1</i>, associated with maternally inherited diabetes and deafness [MIDD] and mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes [MELAS]). The mechanism(s) underlying this purifying selection, however, remain unknown. Here we report that purified patient memory CD4+ T cells have lower bulk m.3243A&gt;G heteroplasmy compared to naïve CD4+ T cells. In vitro activation of naïve CD4+ m.3243A&gt;G patient T cells results in lower bulk m.3243A&gt;G heteroplasmy after proliferation. Finally, m.3243A&gt;G patient T cell receptor repertoire sequencing reveals relative oligoclonality compared to controls. These data support a role for T cell activation in peripheral, purifying selection against high m.3243A&gt;G heteroplasmy T cells at the level of the cell, in a likely cell-autonomous fashion.</p>","PeriodicalId":16281,"journal":{"name":"Journal of Inherited Metabolic Disease","volume":null,"pages":null},"PeriodicalIF":4.2000,"publicationDate":"2024-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11251844/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Inherited Metabolic Disease","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jimd.12726","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

T cells have been shown to maintain a lower percentage (heteroplasmy) of the pathogenic m.3243A>G variant (MT-TL1, associated with maternally inherited diabetes and deafness [MIDD] and mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes [MELAS]). The mechanism(s) underlying this purifying selection, however, remain unknown. Here we report that purified patient memory CD4+ T cells have lower bulk m.3243A>G heteroplasmy compared to naïve CD4+ T cells. In vitro activation of naïve CD4+ m.3243A>G patient T cells results in lower bulk m.3243A>G heteroplasmy after proliferation. Finally, m.3243A>G patient T cell receptor repertoire sequencing reveals relative oligoclonality compared to controls. These data support a role for T cell activation in peripheral, purifying selection against high m.3243A>G heteroplasmy T cells at the level of the cell, in a likely cell-autonomous fashion.

Abstract Image

T 细胞活化有助于针对血液中与 MELAS 相关的 m.3243A>G 致病变体进行净化选择。
研究表明,T 细胞中致病的 m.3243A>G 变异型(MT-TL1,与母系遗传性糖尿病和耳聋 [MIDD] 以及线粒体脑肌病伴乳酸酸中毒和中风样发作 [MELAS])所占比例较低(异形)。然而,这种纯化选择的机制仍然未知。在此,我们报告纯化的患者记忆 CD4+ T 细胞与天真 CD4+ T 细胞相比,具有较低的 m.3243A>G 异质性。体外激活m.3243A>G患者的幼稚CD4+ T细胞会导致增殖后的m.3243A>G异质体较低。最后,与对照组相比,m.3243A>G 患者的 T 细胞受体谱系测序显示出相对的寡克隆性。这些数据支持 T 细胞活化在外周血中的作用,在细胞水平对高 m.3243A>G 异质性 T 细胞进行纯化选择,这很可能是细胞自主的方式。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Inherited Metabolic Disease
Journal of Inherited Metabolic Disease 医学-内分泌学与代谢
CiteScore
9.50
自引率
7.10%
发文量
117
审稿时长
4-8 weeks
期刊介绍: The Journal of Inherited Metabolic Disease (JIMD) is the official journal of the Society for the Study of Inborn Errors of Metabolism (SSIEM). By enhancing communication between workers in the field throughout the world, the JIMD aims to improve the management and understanding of inherited metabolic disorders. It publishes results of original research and new or important observations pertaining to any aspect of inherited metabolic disease in humans and higher animals. This includes clinical (medical, dental and veterinary), biochemical, genetic (including cytogenetic, molecular and population genetic), experimental (including cell biological), methodological, theoretical, epidemiological, ethical and counselling aspects. The JIMD also reviews important new developments or controversial issues relating to metabolic disorders and publishes reviews and short reports arising from the Society''s annual symposia. A distinction is made between peer-reviewed scientific material that is selected because of its significance for other professionals in the field and non-peer- reviewed material that aims to be important, controversial, interesting or entertaining (“Extras”).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信